Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Novavax (NVAX)

Add to Watchlists
Create an Alert
4.13 -0.04  -0.96% NASDAQ Apr 24, 11:12AM BATS Real time Currency in USD
View Full Chart
NVAX Price Chart
View All Events

NVAX Events

Date Type Description
Mar 10 Misc Novavax, Inc. Q4 2013 Earning Conference Call
Mar 10 Earnings Novavax, Inc. Q4 2013 Earning Result. Estimate: -0.08.
Nov 07 Earnings Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013. Estimate: -0.05.
Nov 07 Misc Novavax to Report Third Quarter 2013 Financial Results Conference Call
Sep 24 Misc Novavax to Host an Analyst and Investor Update Call With Webcast
Aug 22 Misc Novavax Acquires Isconova; Extended Public Tender Offer Period Closed
Aug 08 Misc Second Quarter 2013 Financial Conference Call
Aug 08 Earnings Novavax to Report Second Quarter 2013 Financial Results on August 8, 2013. Estimate: -0.06.
Jun 13 Misc AGM Event for Novavax, Inc.
May 07 Misc Q1 2013 Earnings Conference Call
View All Performance Charts

NVAX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novavax is up 63.24% over the last year vs S&P 500 Total Return up 21.64%, Oramed Pharmaceuticals up 68.81%, and Agenus down 42.83%.

Get Quote for

PDF Report for NVAX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NVAX Pro Report PDF
Advertisement

Portfolio Strategies Featuring NVAX

Did Novavax make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NVAX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Novavax, Inc. is a clinical-stage biopharmaceutical company engaged in creating differentiated, value- upon current preventive options for various infectious diseases.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NVAX 4.13 -0.04 -0.96% 861.82M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.